| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.90B | 14.52B | 13.66B | 12.87B | 11.86B | 10.66B |
| Gross Profit | 1.97B | 2.21B | 1.92B | 1.59B | 1.25B | 1.02B |
| EBITDA | 1.21B | 1.11B | 1.17B | 1.06B | 830.32M | 626.71M |
| Net Income | 238.35M | 220.66M | 151.56M | 132.31M | 188.08M | 686.31M |
Balance Sheet | ||||||
| Total Assets | 11.87B | 16.70B | 15.22B | 14.16B | 13.85B | 14.66B |
| Cash, Cash Equivalents and Short-Term Investments | 2.12B | 5.72B | 4.67B | 3.59B | 2.77B | 3.15B |
| Total Debt | 2.59B | 6.59B | 4.60B | 4.04B | 3.97B | 5.19B |
| Total Liabilities | 5.61B | 10.55B | 8.72B | 7.84B | 7.65B | 8.65B |
| Stockholders Equity | 6.25B | 6.15B | 6.50B | 6.32B | 6.20B | 6.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -449.13M | 498.35M | 769.61M | 886.82M | 1.26B |
| Operating Cash Flow | 0.00 | 577.06M | 929.47M | 976.09M | 1.18B | 2.28B |
| Investing Cash Flow | 0.00 | -967.59M | -413.81M | -224.42M | -347.61M | -1.02B |
| Financing Cash Flow | 0.00 | 1.44B | 562.40M | 70.50M | -1.21B | -241.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥15.35B | 14.42 | ― | 1.63% | 5.74% | 31.09% | |
78 Outperform | ¥15.84B | 7.21 | ― | 3.81% | 7.75% | 71.62% | |
76 Outperform | ¥33.14B | 17.48 | ― | 5.00% | 2.53% | -6.30% | |
75 Outperform | ¥42.61B | 6.09 | ― | 2.28% | 7.47% | 12.35% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥13.58B | 36.70 | ― | 0.84% | 7.94% | 48.30% | |
49 Neutral | ¥8.10B | 43.35 | ― | 4.89% | 6.30% | 44.85% |